Comparison of two anesthetic methods for intravitreal ozurdex injection

V Levent Karabaş, Berna Özkan, Çiğdem Akdağ Koçer, Özgül Altıntaş, Dilara Pirhan, Nurşen Yüksel, V Levent Karabaş, Berna Özkan, Çiğdem Akdağ Koçer, Özgül Altıntaş, Dilara Pirhan, Nurşen Yüksel

Abstract

Purpose. To determine whether subconjunctival lidocaine injection maintains additional anesthetic effect during intravitreal Ozurdex injection. Methods. 63 patients who were diagnosed as central or branch retinal vein occlusion and planned to receive Ozurdex injection for macular edema were prospectively included in the study. The patients were randomized into one of the two anesthetic groups. The first group received topical proparacaine drop and lidocaine applied pledget. The second group received subconjunctival lidocaine injection in addition to the anesthetics in group 1. Results. Mean pain score was 1.90 ± 2.39 in group 1 and 1.71 ± 2.09 in group 2 (p = 0.746). Mean subconjunctival hemorrhage grade was 1.67 ± 0.17 in group 1 and 0.90 ± 0.14 in group 2 (p = 0.001). There was no relationship between the amount of subconjunctival hemorrhage and pain score of the patients. Conclusions. There was no difference in pain scores between the two anesthetic methods. The addition of subconjunctival lidocaine injection offered no advantage in pain relief compared to lidocaine-applied pledgets.

References

    1. Peyman G. A., Lad E. M., Moshfeghi D. M. Intravitreal injection of therapeutic agents. Retina. 2009;29(7):875–912. doi: 10.1097/IAE.0b013e3181a94f01.
    1. Stewart M. W. The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clinic Proceedings. 2012;87(1):77–88. doi: 10.1016/j.mayocp.2011.10.001.
    1. American Society of Retina Specialists. Preferences and Trends 2010 Survey. 2010.
    1. Cintra L. P., Lucena L. R., Da Silva J. A., Costa R. A., Scott I. U., Jorge R. Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab. Ophthalmic Surgery Lasers and Imaging. 2009;40(1):13–18. doi: 10.3928/15428877-20090101-05.
    1. Blaha G. R., Tilton E. P., Barouch F. C., Marx J. L. Randomized trial of anesthetic methods for intravitreal injections. Retina. 2011;31(3):535–539. doi: 10.1097/IAE.0b013e3181eac724.
    1. Gregori N. Z., Weiss M. J., Goldhardt R., et al. Randomized clinical trial of two anesthetic techniques for intravitreal injections: 4% liquid lidocaine on cotton swabs versus 3.5% lidocaine gel. Expert Opinion on Drug Delivery. 2012;9(7):735–741. doi: 10.1517/17425247.2012.685155.
    1. Kozak I., Cheng L., Freeman W. R. Lidocaine gel anesthesia for intravitreal drug administration. Retina. 2005;25(8):994–998. doi: 10.1097/00006982-200512000-00007.
    1. Kapoor K. G., Wagner M. G., Wagner A. L. The sustained-release dexamethasone implant: expanding indications in vitreoretinal disease. Seminars in Ophthalmology. 2014 doi: 10.3109/08820538.2014.889179.
    1. Price D. P., McGrath P. A., Rafii A., Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17(1):45–56. doi: 10.1016/0304-3959(83)90126-4.
    1. Salo D., Eget D., Lavery R. F., Garner L., Bernstein S., Tandon K. Can patients accurately read visual analog pain scale? The American Journal of Emergency Medicine. 2003;21(7):515–519. doi: 10.1016/j.ajem.2003.08.022.
    1. Jacobi P. C., Dietlein T. S., Jacobi F. K. Comparative study of topical vs retrobulbar anesthesia in complicated cataract surgery. Archives of Ophthalmology. 2000;118(8):1037–1043. doi: 10.1001/archopht.118.8.1037.
    1. Floman N., Zor U. Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin production. Investigative Ophthalmology & Visual Science. 1977;16(1):69–73.
    1. Cannon C. S., Gross J. G., Abramson I., Mazzei W. J., Freeman W. R. Evaluation of outpatient experience with vitreoretinal surgery. British Journal of Ophthalmology. 1992;76(2):68–71. doi: 10.1136/bjo.76.2.68.
    1. Xing L., Dorrepaal S. J., Gale J. Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada. Canadian Journal of Ophthalmology. 2014;49(3):261–266. doi: 10.1016/j.jcjo.2014.03.009.
    1. Davis M. J., Pollack J. S., Shott S. Comparison of topical anesthetics for intravitreal injections: a randomized clinical trial. Retina. 2012;32(4):701–705. doi: 10.1097/iae.0b013e31822f27ca.
    1. Kaderli B., Avcı R. Comparison of topical and subconjunctival anesthesia in intravitreal injection administrations. European Journal of Ophthalmology. 2006;16(5):718–721.
    1. Yau G. L., Jackman C. S., Hooper P. L., Sheidow T. G. Intravitreal injection anesthesia-comparison of different topical agents: a prospective randomized controlled trial. The American Journal of Ophthalmology. 2011;151(2):333.e2–337.e2. doi: 10.1016/j.ajo.2010.08.031.
    1. LaHood B. R., Franzco D. S., Franzco A. S. Comparative assessment of the effectiveness of anesthesia for intravitreal bevacizumab injection. Clinical & Experimental Ophthalmology. 2011;39(2):184–185.
    1. Blaha G. R. Comparison of topical anesthetics for intravitreal injections: a randomized clinical trial. Retina. 2012;32(7):1440–1440. doi: 10.1097/iae.0b013e31825db86b.
    1. Massaoutis P., Niscopoulou M., Tufail A. Inadvertent intravitreal injection of 0.1 mls of unpreserved lidocaine 2% The Internet Journal of Ophthalmology and Visual Science. 2007;6(1, article 5)
    1. Levy J., Lifshitz T. Lidocaine hypersensitivity after subconjunctival injection. Canadian Journal of Ophthalmology. 2006;41(2):204–206. doi: 10.1139/i06-010.
    1. Tustin A., Kim S. J., Chomsky A., Hubbard G. B., III, Sheng J. Antibacterial properties of 2% lidocaine and reduced rate of endophthalmitis after intravitreal injection. Retina. 2014;34(5):935–942. doi: 10.1097/iae.0000000000000014.
    1. Lyall D. A. M., Tey A., Foot B., et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: Incidence, features, risk factors, and outcomes. Eye. 2012;26(12):1517–1526. doi: 10.1038/eye.2012.199.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera